AT-4526, A New Quinolone Derivative

Its Pharmacokinetics in Cats, Dogs, Pigs, and Calves

Authors

  • Kaoru Kouno Bioscience Research Laboratories, Dainippon Pharmaceutical Co., Ltd. Enoki 33-94, Suita, Osaka 564, Japan
  • Yuzo Sakaguchi Bioscience Research Laboratories, Dainippon Pharmaceutical Co., Ltd. Enoki 33-94, Suita, Osaka 564, Japan
  • Masahiro Nakai Ritto Experimental Farm, Dainippon Pharmaceutical Co., Ltd. Enoki 33-94, Suita, Osaka 564, Japan
  • Motonobu Yoshida Ritto Experimental Farm, Dainippon Pharmaceutical Co., Ltd. Enoki 33-94, Suita, Osaka 564, Japan
  • Shuji Matsumoto Ritto Experimental Farm, Dainippon Pharmaceutical Co., Ltd. Enoki 33-94, Suita, Osaka 564, Japan
  • Tadashi Kawamura Ritto Experimental Farm, Dainippon Pharmaceutical Co., Ltd. Enoki 33-94, Suita, Osaka 564, Japan
  • Naonobu Hatano Ritto Experimental Farm, Dainippon Pharmaceutical Co., Ltd. Enoki 33-94, Suita, Osaka 564, Japan
  • Hiromi Katae Ritto Experimental Farm, Dainippon Pharmaceutical Co., Ltd. Enoki 33-94, Suita, Osaka 564, Japan
  • Hiroaki Hattori Bioscience Research Laboratories, Dainippon Pharmaceutical Co., Ltd. Enoki 33-94, Suita, Osaka 564, Japan
  • Shinichi Nakamura Bioscience Research Laboratories, Dainippon Pharmaceutical Co., Ltd. Enoki 33-94, Suita, Osaka 564, Japan

DOI:

https://doi.org/10.21423/aabppro19926615

Keywords:

quinolone derivative, antibacterial, Mycoplasma spp, gram-positive, gram-negative, pharmacokinetics, AT-4526, cats, dogs, pigs, calves

Abstract

AT-4526, 1-cyclopropyl-5,6,8-trifluoro-1,4-dihydro-7-(cis-3,5-dimethyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid, a new quinolone derivative, is under development as veterinary medicine. It has broad and potent antibacterial activities against gram-positive and gram-negative bacteria, anaerobes and Mycoplasma spp. (1). Its in vivo activity was generally higher than those of structurally related enrofloxacin and certain antibiotics such as oxytetracycline, kanamycin, and ampicillin in experimental infections in mice even in the case of less potent in vitro activity (1).

This paper describes the pharmacokinetics of AT-4526 in cats, dogs, pigs and calves.

Downloads

Published

1992-08-31

Issue

Section

Respiratory Disease

Most read articles by the same author(s)